pyridostigmine bromide has been researched along with Libman-Sacks Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borges, MH; Castro, RC; Kater, CE; Lengyel, AM | 1 |
| Truniger, B | 1 |
| Genth, E; Klein, H; Korz, R | 1 |
1 review(s) available for pyridostigmine bromide and Libman-Sacks Disease
| Article | Year |
|---|---|
[Myasthenia gravis and visceral lupus erythematosus].
Topics: Acetylcholine; Adult; Antibodies, Antinuclear; Antigen-Antibody Complex; Azathioprine; Cell Membrane Permeability; Female; Humans; Lupus Erythematosus, Systemic; Membrane Potentials; Myasthenia Gravis; Plasmapheresis; Prednisone; Pyridostigmine Bromide; Receptors, Cholinergic; Respiration, Artificial | 1979 |
2 other study(ies) available for pyridostigmine bromide and Libman-Sacks Disease
| Article | Year |
|---|---|
Different effects of pyridostigmine on growth hormone (GH) response to GH-releasing hormone in endogenous and exogenous hypercortisolemic patients.
Topics: Adolescent; Adrenocortical Adenoma; Adult; Cushing Syndrome; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hydrocortisone; Lupus Erythematosus, Systemic; Male; Pituitary Neoplasms; Pyridostigmine Bromide; Somatostatin; Time Factors | 1993 |
[Myasthenia gravis and LE nephritis: problems of treatment with cholinesterase inhibitors during long-term dialysis (author's transl)].
Topics: Female; Humans; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Middle Aged; Myasthenia Gravis; Nephritis; Pyridostigmine Bromide; Renal Dialysis | 1978 |